| Patents for C07C 225 - Compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton, at least one of the doubly-bound oxygen atoms not being part of a cho group, e.g. amino ketones (4,302) |
|---|
| 01/30/2002 | EP1175388A1 Spect imaging agents for serotonin transporters |
| 01/30/2002 | EP1175383A1 Glucocorticoid receptor modulators |
| 01/29/2002 | US6342496 Bupropion metabolites and methods of use |
| 01/24/2002 | WO2002006210A1 Phenyl amino squarate and thiadiazole dioxide beta-3 adrenergic receptor agonists |
| 01/24/2002 | US20020010178 1-phenyl-3-dimethylaminopropane compounds with a pharmacological effect |
| 01/23/2002 | CN1332161A Method for preparing sulfamine urea compound |
| 01/23/2002 | CN1332160A Process for prep. of 4-hydroxy-phenyl butanone |
| 01/22/2002 | CA2024956C Isoxazoles herbicides |
| 01/17/2002 | WO2001046125A3 Cd45 inhibitors |
| 01/16/2002 | EP1171566A1 Pro-fragrances |
| 01/16/2002 | EP0923527B1 A process for the preparation of 2-(3-benzoyl-phenyl)-propionic acid starting from aryl-olefins |
| 01/10/2002 | WO2002002516A2 Inhibitors of hiv integrase |
| 01/10/2002 | WO2002002507A1 2-hydroxy-5-amino-biphenyl-derivatives and oxidative hair colouring agents containing said compounds |
| 01/10/2002 | CA2383577A1 2-hydroxy-5-aminobiphenyl derivatives and oxidative hair dyes containing these compounds |
| 01/09/2002 | EP0778263B1 Benzene compound and medicinal use thereof |
| 01/09/2002 | CN1330063A Propanedione derivative and use as polymerized ultraviolet absorber |
| 01/09/2002 | CN1077566C 1-phenyl-3-dimethylaminopropane compounds with pharmacological effect |
| 01/08/2002 | US6337328 Bupropion metabolites and methods of use |
| 01/03/2002 | WO2002000609A2 2,6,7-substituted tetralines useful for the preparation of medicaments with phosphodiesterase iv inhibitory activity |
| 01/03/2002 | WO2002000586A1 The novel propanedione derivatives and their use as polymerizable uv-absorbent |
| 01/03/2002 | US20020002169 Protein kinase inhibitors |
| 01/02/2002 | EP1167342A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 01/02/2002 | EP1165086A2 Bupropion metabolites and methods of their synthesis and use |
| 01/01/2002 | CA2010217C Aralkylamine compounds |
| 12/27/2001 | WO2001098265A2 Process for isolating enantiomers of racemic cetamine |
| 12/27/2001 | WO2001098251A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 12/27/2001 | US20010056107 Cyano and carboxy derivatives of substituted styrenes are inhibitors of tumor necrosis factor alpha , nuclear factor kappa B, and phosphodiesterase and can be used to treat cachexia, endotoxic shock, inflammatory conditions etc. |
| 12/27/2001 | US20010056092 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 12/26/2001 | CN1327976A Benzoxazinone compounds asymmetrically synthesized from new intermediate |
| 12/21/2001 | CA2351129A1 Novel substituted nitrocatechols, their use in the treatment of some central and peripheral nervous system disorders and pharmaceutical compositions containing them |
| 12/20/2001 | WO2001096278A2 A novel process for preparing salmeterol |
| 12/20/2001 | US20010053863 Curable allyl homopolymer |
| 12/19/2001 | CN1326924A Process for preparing high purity 2-amino-5-chloro-2'-diphenyl ketone |
| 12/13/2001 | WO2001094357A1 Antitumoral compounds |
| 12/13/2001 | US20010049848 Direct dyes; hair dyes |
| 12/13/2001 | DE10032134C1 Compositions for oxidative dyeing of keratinic fibers, especially human hair, comprise new or known 2-hydroxy-5-amino-biphenyl derivatives as developers |
| 12/13/2001 | CA2410409A1 Antitumoral compounds |
| 12/11/2001 | US6329551 High temperature stability |
| 12/11/2001 | US6329405 As ileal bile acid transporter inhibitor, for therapy of hyperlipemia |
| 12/11/2001 | US6329399 Antifungal amine derivatives and processing for producing the same |
| 12/06/2001 | WO2001092202A1 Il-8 receptor antagonists |
| 12/06/2001 | CA2411323A1 Il-8 receptor antagonists |
| 12/04/2001 | US6326369 Bicyclic quinone compounds, their production and use |
| 11/29/2001 | WO2001089504A1 Tropolone derivatives and pharmaceutical compositions |
| 11/28/2001 | EP1157617A2 Use of alpha-keto enamine derivatives as ingredients |
| 11/28/2001 | EP0906268B1 Alkyloxyamino substituted fluorenones and their use as protein kinase c inhibitors |
| 11/23/2001 | CA2348301A1 Use of alpha-keto enamine derivatives as ingredients |
| 11/20/2001 | US6320063 Heating dichlorophthalic anhydride over layer of powdered anhydrous sodium and/or potassium fluoride under nitrogen atmosphere to produce difluorophthalic anhydride intermediate |
| 11/15/2001 | CA2415040A1 An improved process for the preparation of quinolone derivatives |
| 11/07/2001 | EP1151990A1 Substituted N-arylmethylamino derivatives of cyclobutene-3, 4-diones |
| 11/06/2001 | US6313175 For therapy of obesity; for quantitating the binding of serotonin or a serotonin ligand |
| 11/06/2001 | US6313174 Aminobenzophenones as inhibitors of interleukin and TNF |
| 11/06/2001 | US6313146 Calcium receptor-active molecules |
| 11/06/2001 | US6313132 Therapeutically active diarylpropylamines; their pharmaceutically acceptable salts; a method for their preparation and method for their use |
| 11/04/2001 | CA2346149A1 Photo-reactive benzocyclobutenones and polymers therefrom for self-photocuring, photo-crosslinking and photopatterning without catalysts |
| 10/31/2001 | EP0876356B1 Use of tricyclic 1,4-dihydro-1,4-dioxo-1h-naphthalene derivatives, resulting novel compounds and therapeutical use thereof |
| 10/30/2001 | US6310249 Process for producing 2-aminobenzophenone compound |
| 10/25/2001 | WO2001078713A1 Phenylethylamines and condensed rings variants as prodrugs of catecholamines, and their use |
| 10/25/2001 | US20010033944 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied |
| 10/24/2001 | EP1148046A1 Process for the preparation of alpha-aminoketones |
| 10/23/2001 | US6307087 Ligands for metals and improved metal-catalyzed processes based thereon |
| 10/17/2001 | EP1146034A1 Light-emitting material for organic electroluminescence device, and organic electroluminescence device for which the light-emitting material is adapted |
| 10/17/2001 | CN1073086C Improved process for mfg. cycloalkyl and haloalkyl O-aminophenyl ketones |
| 10/10/2001 | EP1142865A1 Novel 1,2-diphenyl-2-propen-1-one derivatives |
| 10/10/2001 | EP1140200A1 Anthraquinone anticancer drugs |
| 10/09/2001 | US6300376 Indane dimer compounds and their pharmaceutical use |
| 10/04/2001 | US20010027253 Photoactivatable nitrogen-containing bases based on alpha-amino ketones |
| 10/02/2001 | US6297401 A 3-nitrosalicylamide derivative effective against plant pytopathogens |
| 10/02/2001 | US6297399 Hypotensive agents |
| 09/27/2001 | WO2001070675A2 Inhibitors of histone deacetylase |
| 09/27/2001 | WO2001062705A8 Aminoalcohol derivatives |
| 09/27/2001 | CA2404002A1 Inhibitors of histone deacetylase |
| 09/26/2001 | EP1135365A1 4-3-substituted-amino-cyclobut-3-ene-1,2-diones and use for influencing smooth muscle contraction |
| 09/26/2001 | EP0844236B1 Process for producing carbamoylmethylurea derivatives |
| 09/20/2001 | WO2001068654A2 Tubulin binding ligands and corresponding prodrug constructs |
| 09/18/2001 | CA2168364C Stabilized pharmaceutical composition containing bupropion |
| 09/08/2001 | CA2300502A1 Process for the preparation of a polyaromatic compound |
| 09/07/2001 | WO2001064208A1 Il-8 receptor antagonists |
| 09/07/2001 | CA2401659A1 Il-8 receptor antagonists |
| 08/30/2001 | WO2001062705A2 Aminoalcohol derivatives |
| 08/30/2001 | WO2001062257A2 Bupropion metabolites and methods of their synthesis and use |
| 08/29/2001 | CN1310703A Process for producing 2-aminobenzophenone compound |
| 08/29/2001 | CN1070170C Process for producing 4-halo-2'-nitrobutyrophenone compound |
| 08/28/2001 | US6281295 Enamines as vulcanization accelerators for natural or synthetic rubbers |
| 08/28/2001 | US6280859 Light-emitting material for organo-electroluminescence device and for organic electroluminescence device which the material is applied |
| 08/28/2001 | CA2017252C Retroviral protease inhibiting compounds |
| 08/23/2001 | WO2001060781A2 Diphenyl compounds, formulations and uses thereof |
| 08/23/2001 | WO2001010816A3 Substituted 2-dialkylaminoalkylbiphenyl derivatives |
| 08/22/2001 | CN1069813C 1-[[o-(cyclopropylcarbonyl)-phenyl]sulfamoyl]-3-(4,6-dimethoxy-2-pyrimidinyl) urea as herbicide |
| 08/21/2001 | US6277986 Photoactivatable nitrogen-containing bases based on α-amino ketones |
| 08/16/2001 | EP1123271A1 Novel amine and quaternary ammonium compounds made from ketones and aldehydes, and compositions containing them |
| 08/15/2001 | CN1308604A 2,3,5-substituted biphenyls useful in the treatment of insulin resistance and hyperglycemia |
| 08/14/2001 | CA2187591C Novel tertiary heterocyclic amines; process for preparing them and pharmaceutical compositions containing them |
| 07/25/2001 | EP1117633A1 Diaminocyclobutene-3,4-dione derivatives, their preparation and use |
| 07/24/2001 | US6265614 Reacting lithium compound containing amine grop with amide compound to form neurokinin antagonists |
| 07/18/2001 | EP1115695A1 (r)-chiral halogenated 1-substitutedamino-(n+1)-alkanols useful for inhibiting cholesteryl ester transfer protein activity |
| 07/18/2001 | EP1115693A1 SUBSTITUTED POLYCYCLIC ARYL AND HETEROARYL $i(TERTIARY)-HETEROALKYLAMINES USEFUL FOR INHIBITING CHOLESTERYL ESTER TRANSFER PROTEIN ACTIVITY |
| 07/18/2001 | CN1304399A Process for preparation of amides |
| 07/17/2001 | US6262101 Alpha-pyrrolidine, imidazole and thiophene-substituted styrene derivatives; inhibitors of tumor necrosis factor alpha, nuclear factor kappa b, and phosphodiesterase |
| 07/17/2001 | US6262095 Use of tricyclic derivatives of 1,4-dihydro-1,4-dioxo-1H-naphthalene, novel compounds obtained and their application in theraphy |